RFC
IRMD icon

Russell Frank Company’s iRadimed IRMD Stock Holding History

Russell Frank Company’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$2.45M Buy
127,908
+32,796
+34% +$628K ﹤0.01% 1747
2015
Q4 		$2.67M Buy
+95,112
New +$2.69M ﹤0.01% 1666

Other funds holding IRMD

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.71B AUM 65.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $1B AUM 50.12% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Russell Frank Company's IRMD Position: Q1 2016 in Review

Russell Frank Company increased its iRadimed (IRMD) stake by 34% in Q1 2016, buying an estimated $628K and bringing the position to 127,908 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1747.

Russell Frank Company first reported a position in IRMD in Q4 2015 and has held it in 2 quarters since. The position peaked at $2.67M in Q4 2015. 66 funds tracked by Wall St. Rank hold IRMD as of Q1 2016.

  • Russell Frank Company held 127,908 shares of iRadimed worth $2.45M as of Q1 2016.
  • Russell Frank Company bought 32,796 iRadimed shares in Q1 2016, an estimated $628K.
  • iRadimed made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1747 holding.
  • Russell Frank Company first reported a position in iRadimed in Q4 2015 and has held it in 2 quarters since.
  • Russell Frank Company's iRadimed position peaked at $2.67M in Q4 2015.
  • 66 funds tracked by Wall St. Rank held iRadimed as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.